FDA is Right to Restrict 7-hydroxymitragynine (7-OH) Products WholeFoods Magazine On July 29, the FDA announced it would seek to restrict 7-OH under the Controlled Substances Act, two weeks after the Administration issued warning letters to seven 7-OH manufacturers
Whether youre dealing with fatigue, dehydration, or just want to boost your immune system, this treatment can help you feel your best
After your first month of treatment, adding the Precision Peptide Genetic Test ($298) reveals your peptide-pathway profile and allows your PlexusDx team to customize your supplement strategy for maximum preservation of lean mass while maximizing fat loss
Compounded medications allow your provider to adjust your dose based on your individual response and tolerance, not preset commercial pen increments
Authorization process Physicians can refer patients to the program by submitting a prescription for a covered GLP-1 drug to the patients pharmacy along with a diagnosis code for overweight or obesity from the E66 family of ICD-10 codes